The Longitude Prize on AMR

This prize closed on 30 September 2022. Final submissions are now undergoing independent testing as the last stage of the assessment process.

The Longitude Prize on AMR is a £10m prize fund, with an £8m pay-out, that will reward a team of innovators who develop a point–of–care diagnostic test that will conserve antibiotics for future generations. The test must be accurate, rapid, affordable and easy to use anywhere in the world.

This Prize is now closed. What happens next? 

After assessing the results of the independent testing, the Prize Advisory Panel (PAP) will form final recommendations to the Longitude Committee on whether to award the prize.

A final decision on the outcome of the prize can be expected in early 2024.

Our latest news & views

Introducing The Longitude Prize on Dementia; the second instalment of the modern Longitude Prize

Press Release

60-minute diagnostic tests tackling antibiotic resistance to be eligible for £8m Longitude Prize

Press Release

India’s growing biotech ecosystem in the fight against antimicrobial resistance

Blog

Watch AMR& Diagnostic Frontiers Event with CARB-X and FIND

Event

A Technical Read: Improved UTI Diagnostics: AST without Identification – Ready for “Primetime”?

Blog

Ensuring access to tackle the growing global threat of antimicrobial resistance

Blog

The future of AMR diagnostics

Blog

Tackling AMR: A high-level interactive dialogue

Blog